Evidence map›Paper›PMID 20171611›Full record

ArticleCellular immunology2010

Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immunodeficiency patients.

Danilo Escobar, Jaime Pons, Antonio Clemente, Julio Iglesias, Verónica Regueiro, José A Bengoechea, Nuria Matamoros, Joana M Ferrer

Abstract read
PubMed Publisher
In one paragraph

Article in Cellular immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Toll-like receptor signaling in primary immune deficiencies.Annals of the New York Academy of Sciences · 2015
    Review
  5. Rare variants at 16p11.2 are associated with common variable immunodeficiency.The Journal of allergy and clinical immunology · 2015
    Article
  6. Toll-like receptor function in primary B cell defects.Frontiers in bioscience (Elite edition) · 2012
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Danilo EscobarServei d'Immunologia, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Hospital Son Dureta, Palma de Mallorca, Spain.
Jaime Pons
Antonio Clemente
Julio Iglesias
Verónica Regueiro
José A Bengoechea
Nuria Matamoros
Joana M Ferrer
Research Institute of Health Sciences · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESServei de Salut de les Illes Balears · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinaemia and antibody deficiency to both T dependent and independent antigens. Patients suffer from recurrent sinopulmonary infections mostly caused by Streptococcus pneumoniae and Haemophilus influenzae, but also gastrointestinal or autoimmune symptoms. Their response to vaccination is poor or absent. In this study we investigated B cell activation induced by the TLR9 specific ligand (CpG-ODN) and bacterial extracts from S. pneumoniae and H. influenzae known to stimulate several TLR. We found that B cells from CVID patients express lower levels of CD86 after stimulation with CpG-ODN, S. pneumoniae and H. influenzae extracts in combination with anti-IgM antibody and also display a lower proliferative index when stimulated with bacterial extracts. Our results point to a broad TLR signalling defect in B lymphocytes from CVID patients that may be related to the hypogammaglobulinaemia and poor response to vaccination characteristic of these patients.

Indexed as

AdultAgedAnimalsAntigens, CD19B7-2 AntigenB-LymphocytesCell ExtractsCell ProliferationCommon Variable ImmunodeficiencyFemaleHaemophilus influenzaeHumansLigandsMaleMiddle AgedOligodeoxyribonucleotidesAntigens, CD19B7-2 AntigenCell ExtractsCPG-oligonucleotideLigandsOligodeoxyribonucleotidesToll-Like Receptor 9

Identifiers

PMID20171611
OpenAlexW2071240773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.